CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Booth Bruce Director | Sale 10b5-1 | −848 | $105.78 | $90K | 471,419 |
| 2026-06-29 | Booth Bruce Director | Sale 10b5-1 | −2,318 | $106.63 | $247K | 469,101 |
| 2026-06-29 | Booth Bruce Director | Sale 10b5-1 | −3,024 | $107.76 | $326K | 466,077 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −28,296 | $107.57 | $3.0M | 2,834,055 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −231,007 | $108.14 | $25.0M | 2,603,048 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −32,624 | $109.79 | $3.6M | 2,570,424 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −11,277 | $110.49 | $1.2M | 2,559,147 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −10,366 | $111.51 | $1.2M | 2,548,781 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −555 | $112.49 | $62K | 2,548,226 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −14,913 | $113.97 | $1.7M | 2,533,313 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −27,951 | $114.94 | $3.2M | 2,505,362 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −6,821 | $115.69 | $789K | 2,498,541 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −12,181 | $117.09 | $1.4M | 2,486,360 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −22,046 | $117.85 | $2.6M | 2,464,314 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −12,390 | $118.66 | $1.5M | 2,451,924 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −3,958 | $107.57 | $426K | 525,760 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −32,402 | $108.14 | $3.5M | 493,358 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −4,562 | $109.79 | $501K | 488,796 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −1,579 | $110.49 | $174K | 487,217 |
| 2026-06-26 | Booth Bruce Director | Sale 10b5-1 | −1,442 | $111.51 | $161K | 485,775 |
Page 4 of 25 · 493 trades